Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Tomasoni

Showing results (111-120 of 202) with videos related to

Pageof 21
Sort By:
European Journal of Heart Failure|December 22, 2023
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure RegistryDaniela Tomasoni, Cristiana Vitale, Federica Guidetti, et al.
Current Cardiology Reports|August 19, 2021
Vericiguat for Heart Failure with Reduced Ejection FractionCarlo Mario Lombardi, Giuliana Cimino, Matteo Pagnesi, et al.
Frontiers in Cardiovascular Medicine|March 31, 2023
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosisAngelica Cersosimo, Andrea Bonelli, Carlo M Lombardi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 16, 2024
Management of hypertrophic cardiomyopathyYuhui Zhang, Marianna Adamo, Changhong Zou, et al.
European Journal of Heart Failure|September 10, 2024
The Mayo ATTR-CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosisGiovanni Battista Bonfioli, Daniela Tomasoni, Giuseppe Vergaro, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 17, 2020
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarctionDaniela Tomasoni, Marianna Adamo, Leonardo Italia, et al.
Heart Failure Reviews|May 17, 2023
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?Mauro Riccardi, Antonio M Sammartino, Marianna Adamo, et al.
ESC Heart Failure|May 28, 2024
2024 update in heart failureAlberto Beghini, Antonio Maria Sammartino, Zoltán Papp, et al.
Frontiers in Cardiovascular Medicine|June 8, 2023
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trialsDaniela Tomasoni, Giovanni Battista Bonfioli, Alberto Aimo, et al.
European Journal of Internal Medicine|June 12, 2025
Gamma-glutamyltransferase independently predicts mortality and heart failure hospitalization in cardiac transthyretin amyloidosisAlberto Aimo, Vincenzo Castiglione, Daniela Tomasoni, et al.
Pageof 21

Showing results (111-120 of 202) with videos related to

Sort By:
Pageof 21
European Journal of Heart Failure|December 22, 2023
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure RegistryDaniela Tomasoni, Cristiana Vitale, Federica Guidetti, et al.
Current Cardiology Reports|August 19, 2021
Vericiguat for Heart Failure with Reduced Ejection FractionCarlo Mario Lombardi, Giuliana Cimino, Matteo Pagnesi, et al.
Frontiers in Cardiovascular Medicine|March 31, 2023
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosisAngelica Cersosimo, Andrea Bonelli, Carlo M Lombardi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 16, 2024
Management of hypertrophic cardiomyopathyYuhui Zhang, Marianna Adamo, Changhong Zou, et al.
European Journal of Heart Failure|September 10, 2024
The Mayo ATTR-CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosisGiovanni Battista Bonfioli, Daniela Tomasoni, Giuseppe Vergaro, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|September 17, 2020
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarctionDaniela Tomasoni, Marianna Adamo, Leonardo Italia, et al.
Heart Failure Reviews|May 17, 2023
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?Mauro Riccardi, Antonio M Sammartino, Marianna Adamo, et al.
ESC Heart Failure|May 28, 2024
2024 update in heart failureAlberto Beghini, Antonio Maria Sammartino, Zoltán Papp, et al.
Frontiers in Cardiovascular Medicine|June 8, 2023
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trialsDaniela Tomasoni, Giovanni Battista Bonfioli, Alberto Aimo, et al.
European Journal of Internal Medicine|June 12, 2025
Gamma-glutamyltransferase independently predicts mortality and heart failure hospitalization in cardiac transthyretin amyloidosisAlberto Aimo, Vincenzo Castiglione, Daniela Tomasoni, et al.
Pageof 21